Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
soybean oil + olive oil + fish oil + medium-chain triglycerides
- Development stage
- Approved
- Lead developer
- Fresenius Kabi
- Modality
- Nanoparticles → Drug Delivery Systems
- Administration
- Intravenous
01
Overview
**Soybean oil + olive oil + fish oil + medium-chain triglycerides** is a four-component **intravenous lipid emulsion** used as part of **parenteral nutrition** to provide calories and essential fatty acids when oral or enteral feeding is not possible, insufficient, or contraindicated. Marketed as **SMOFlipid**, it contains a defined mixture of soybean oil, medium-chain triglycerides, olive oil, and fish oil, and is formulated to reduce omega-6 exposure while supplying monounsaturated fatty acids, omega-3 fatty acids, and vitamin E. Its therapeutic effect is nutritional rather than receptor-targeted: it replenishes lipid calories and essential fatty acids and helps maintain fatty acid balance in patients requiring intravenous nutrition, including adults, children, and term and preterm neonates. The product has been developed and commercialized for hospital parenteral nutrition use, with clinical experience particularly in neonatal, pediatric, and intensive care settings.
- Brand names
- SMOFlipid
- Other names
- soybean oil + olive oil + fish oil + medium-chain triglyceridessoybean oil + medium-chain triglycerides + olive oil + fish oilintravenous lipid emulsion
Beyond the preview
Go deeper on soybean oil + olive oil + fish oil + medium-chain triglycerides.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on soybean oil + olive oil + fish oil + medium-chain triglycerides.